Modulating Vimentin: A Systems-Level Therapeutic Strategy for Sepsis and Complex Diseases

TL;DR

This paper proposes targeting the protein vimentin as a new strategy to treat sepsis by restoring balance in the body's complex systems.

Contribution

The paper introduces vimentin as a systems-level therapeutic target for sepsis and complex diseases.

Findings

Vimentin acts as a network integrator across immune, vascular, and metabolic systems.

Vimentin overactivation in sepsis leads to systems-level instability and organ dysfunction.

Modulating vimentin offers a strategy to realign host response networks in sepsis.

Abstract

Sepsis remains a leading global health challenge, characterized by high mortality and a persistent lack of disease-modifying therapies. Despite decades of investment, therapeutic progress has been constrained by reductionist strategies that target isolated pathogenic components. This perspective argues that these failures reflect a fundamental mischaracterization of sepsis—not as a disorder of discrete pathways, but as the collapse of complex biological systems in which normally coordinated processes become desynchronized. We identify the intermediate filament protein vimentin as a determinant of system fate governing the transition from adaptive host defense to pathological breakdown. Acting as a context-dependent network integrator and signal amplifier, vimentin coordinates antagonistic cellular programs by integrating biochemical and biophysical cues across immune, vascular, and metabolic systems. Under physiological stress, this coordination enables the orderly activation and resolution of inflammatory and suppressive responses required for pathogen control and restoration of homeostasis. In sepsis, persistent or excessive insults drive vimentin-mediated overactivation, uncoupling these programs and propagating systems-level instability that culminates in organ dysfunction. By integrating mechanistic, preclinical, and emerging clinical evidence, this perspective proposes vimentin modulation as a clinically translatable, systems-oriented strategy aimed at realigning host response networks to address the dynamic, opposing pathologies of sepsis that have eluded current therapies.

Figures